Thus, natural history studies and clinical prevention trials should pinpoint the optimal stage of pathogenesis at which to interfere with IL-2, IL-6 or TYK2 signalling to prevent type 1 diabetes. This evidence concerns the gene TYK2 and type 1 diabetes mellitus.